Cargando…
Rapid Generation of Circulating and Mucosal Decoy Human ACE2 using mRNA Nanotherapeutics for the Potential Treatment of SARS‐CoV‐2
Severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) can cause lethal pulmonary damage in humans. It contains spike proteins on its envelope that bind to human angiotensin‐converting enzyme 2 (hACE2) expressed on airway cells, enabling entry of the virus, and causing infection. The soluble f...
Autores principales: | Kim, Jeonghwan, Jozic, Antony, Mukherjee, Anindit, Nelson, Dylan, Chiem, Kevin, Khan, Md Siddiqur Rahman, Torrelles, Jordi B., Martinez‐Sobrido, Luis, Sahay, Gaurav |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9762296/ https://www.ncbi.nlm.nih.gov/pubmed/36216580 http://dx.doi.org/10.1002/advs.202202556 |
Ejemplares similares
-
Naturally Derived Membrane Lipids Impact Nanoparticle-Based Messenger RNA Delivery
por: Kim, Jeonghwan, et al.
Publicado: (2020) -
Engineered mutant α-ENaC subunit mRNA delivered by lipid nanoparticles reduces amiloride currents in cystic fibrosis–based cell and mice models
por: Mukherjee, Anindit, et al.
Publicado: (2020) -
Engineering ACE2 decoy receptors to combat viral escapability
por: Arimori, Takao, et al.
Publicado: (2022) -
Self-assembled mRNA vaccines
por: Kim, Jeonghwan, et al.
Publicado: (2021) -
Outsmarting SARS-CoV-2 by empowering a decoy ACE2
por: Sokolowska, Milena
Publicado: (2020)